BioLineRx(BLRX)

0.8500 -0.0216 -2.4785%

今开:0.8734昨收:0.871603
最高:0.89 最低:0.813
涨停价:0.0跌停价:0.0
总市值:6.7948385E7

BioLineRx的热门讨论

财报披露

BioLineRx(BLRX)05-06 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-28 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-24 19:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-18 05:15

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接查看全文

财报披露

BioLineRx(BLRX)05-30 19:25

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接查看全文

BioLineRx的最新讨论

挟韭菜以令诸国2020-12-04 23:49

$BioLineRx(BLRX)$ 留印。雄起!查看全文

皮神超级欧2020-11-10 05:19

$BioLineRx(BLRX)$ 这家也来赌个财报查看全文

皮神超级欧2020-11-04 00:29

$BioLineRx(BLRX)$ 后来直上,[牛]不过我不玩了,凡是我赚了钱了再玩基本就是亏,还是眼不见为净查看全文

皮神超级欧2020-10-30 23:19

$BioLineRx(BLRX)$ 猜对了,2.1进2.7出,赚了2.5k,这次设了limit,虽然没赚满但足够了查看全文

鲜克有终72020-10-30 23:06

$BioLineRx(BLRX)$ [吐血][吐血]原来你才是王者吗查看全文

chuminhua2019-12-14 11:38

12/13,BioLineRx公司$BioLineRx(BLRX)$ 在欧洲肿瘤内科学会免疫肿瘤学大会(ESMO IO)上公布了该公司开发的BL-8040与PD-1抗体Keytruda,以及化疗联用,治疗转移性胰腺癌患者的2a期临床试验结果。BL-8040是一款靶向趋化因子受体CXCR4的多肽类拮抗剂。在名为COMAT/KEYNOTE-202的2a期临床试验中,能...查看全文

狂拉的麦克斯2019-12-05 22:01

$BioLineRx(BLRX)$ Preliminary data from a Phase 2a clinical trial, COMBAT/KEYNOTE-202, evaluating BioLineRx's (NASDAQ:BLRX) lead oncology candidate BL-8040, combined with Merck's Keytruda and chemo, in metastatic pancreatic cancer patients showed a positive effect (th...查看全文

王王可可2019-05-18 17:50

$BioLineRx(BLRX)$ 这股什么情况查看全文

忘江2018-10-22 13:34

$BioLineRx Ltd. - American Depositary Shares(BLRX)$
The results presented today at a poster discussion session at the European Society for Medical Oncology 2018 Congress, in Munich, Germany, demonstrate that BL-8040 significantly improves T-cell infiltration into the tum...查看全文

静思观语2018-10-21 06:27

$BioLineRx Ltd. - American Depositary Shares(BLRX)$ 在#ESMO18 进一步披露的 关于BL-8040 and Pembrolizumab针对胰腺癌联合用药2a实验结果看起来挺不错的。网页链接查看全文

1 2 3 4 5 6 7 8

BioLineRx的公告

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001889  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001842  Act: 34  Size: 1 MB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001827  Act: 34  Size: 599 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001769  Act: 34  Size: 588 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001582  Act: 34  Size: 607 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001347  Act: 34  Size: 612 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001285  Act: 34  Size: 595 KB 网页链接

财报披露

$BioLineRx(BLRX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001178913-24-001174  Act: 34  Size: 1 MB 网页链接

招股说明书

$BioLineRx(BLRX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001178913-24-001173  Act: 33  Size: 733 KB 网页链接

年度财报「修正」

$BioLineRx(BLRX)$ 20-F/A [Amend] Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001178913-24-001095  Act: 34  Size: 14 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40